Reversible monoamine oxidase type A inhibitor. Prepn: C. Fauran et al., DE 2012120; eidem, US 3655687 (1970, 1972 both to Delalande); eidem, Chim. Ther. 8, 324 (1973). Pharmacology: G. Raynaud et al., ibid. 328. Psychopharmacological profile: J.-P. Kan et al., Eur. J. Med. Chem. 12, 13 (1977); H. Giono-Barber et al., Arzneim.-Forsch. 27, 1188 (1977). Pharmacokinetics: M. S. Benedetti et al., ibid. 32, 276 (1982). Metabolism: A. Malnoe, M. S. Benedetti, Xenobiotica 9, 281 (1979). GLC determn in plasma: S. Vajta et al., J. Chromatogr. 274, 139 (1983). Clinical evaluation in panic disorder: G. Perna et al., J. Clin. Psychopharmacol. 14, 414 (1994).
Antidepressant.
Antidepressant; Phenyloxazolidinones; Monoamine Oxidase Inhibitor